Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$10.5M Hold
306,820
0.76% 27
2017
Q3
$10.4M Sell
306,820
-28,526
-9% -$917K 0.67% 31
2017
Q2
$10.7M Sell
335,346
-72,180
-18% -$2.28M 0.66% 32
2017
Q1
$13.2M Buy
407,526
+32,775
+9% +$1.03M 0.73% 24
2016
Q4
$11.5M Sell
374,751
-83,739
-18% -$2.56M 0.8% 28
2016
Q3
$14.7M Buy
458,490
+231,985
+102% +$7.76M 1.05% 14
2016
Q2
$7.57M Sell
226,505
-254,880
-53% -$8.13M 0.57% 51
2016
Q1
$13.5M Sell
481,385
-230,389
-32% -$6.58M 0.85% 22
2015
Q4
$21.8M Sell
711,774
-888,382
-56% -$27.9M 1.3% 8
2015
Q3
$47.7M Buy
1,600,156
+218,985
+16% +$7.02M 1.19% 17
2015
Q2
$43.9M Sell
1,381,171
-28,492
-2% -$929K 0.93% 22
2015
Q1
$46.5M Sell
1,409,663
-754,148
-35% -$24M 1.33% 9
2014
Q4
$63.9M Buy
2,163,811
+821,698
+61% +$23.6M 1.92% 2
2014
Q3
$37.7M Buy
1,342,113
+80,511
+6% +$2.26M 1% 6
2014
Q2
$35.5M Sell
1,261,602
-39,917
-3% -$1.14M 1.05% 5
2014
Q1
$39.7M Buy
+1,301,519
New +$38.8M 1.33% 5

Other funds holding PFE

GLG LLC's PFE Position: Q4 2017 in Review

GLG LLC held its Pfizer (PFE) position steady in Q4 2017 at 306,820 shares worth $10.5M. The position accounts for 0.76% of the portfolio, ranked #27.

GLG LLC first reported a position in PFE in Q1 2014 and has held it in 16 quarters since. The position peaked at $63.9M in Q4 2014. 2,243 funds tracked by Wall St. Rank hold PFE as of Q4 2017.

  • GLG LLC held 306,820 shares of Pfizer worth $10.5M as of Q4 2017.
  • GLG LLC left its Pfizer share count unchanged in Q4 2017.
  • Pfizer made up 0.76% of GLG LLC's portfolio in Q4 2017, its #27 holding.
  • GLG LLC first reported a position in Pfizer in Q1 2014 and has held it in 16 quarters since.
  • GLG LLC's Pfizer position peaked at $63.9M in Q4 2014.
  • 2,243 funds tracked by Wall St. Rank held Pfizer as of Q4 2017.

Based on GLG LLC's 13F filing for Q4 2017, filed 14 Feb 2018.